Context: Cognitive impairment is a relatively less known and less addressed complication of diabetes. It is a concern because it adversely affects disease self-management resulting in further complications. The incidence of cognitive impairment in adults with diabetes has been demonstrated in a small number of research, particularly when using the MoCA (The Montreal Cognitive Assessment) score, which assesses various domains of cognition. Aims: The aim of the study is to investigate the prevalence of cognitive impairment in adults with type 2 diabetes mellitus and to identify other potential predictors for cognitive impairment. Settings and Design: Comparative study in non-diabetics and diabetics Methods and Material: 60 people participated in the study. They were further divided into Non-Diabetics (Group A) and Diabetics (Group B). The MoCA score was used to screen for cognitive impairment. Statistical analysis used: Statistical analysis was done using Microsoft Excel and SPSSv.29. Subjects with cognitive impairment did not show significant association with disease characteristics such as duration of diabetes [P 0.240] and control of diabetes [P 0.192]. Results: Most of the diabetic population were females that had cognitive impairment. The total MoCA score in diabetics [mean- 21] was less compared to the non-diabetic patients [mean-28]. The diabetics also scored lower on every domain of MoCA when compared to the non-diabetic group. However, not all domains were affected the same. Conclusions: This study concludes that cognitive impairment was present in most of the diabetic population. Duration of diabetes and Control of diabetes did not show an association with cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Vispute et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: